Rupali Kohal[Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Fyn, Blk, and Lyn kinase inhibitors: A mini-review on medicinal attributes, research progress, and future insights.

Kohal R, Bhavana, Kumari P, Sharma AK, Gupta GD, Verma SK. Kohal R, et al. Bioorg Med Chem Lett. 2024 Apr 1;102:129674. doi: 10.1016/j.bmcl.2024.129674. Epub 2024 Feb 24. Bioorg Med Chem Lett. 2024. PMID: 38408513 Review.

Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations.

Kohal R, Bisht P, Gupta GD, Verma SK. Kohal R, et al. Bioorg Chem. 2024 Feb;143:107095. doi: 10.1016/j.bioorg.2023.107095. Epub 2024 Jan 4. Bioorg Chem. 2024. PMID: 38211548 Review.

Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.

Bhavana, Kohal R, Kumari P, Das Gupta G, Kumar Verma S. Bhavana, et al. Among authors: kohal r. Bioorg Chem. 2024 Mar;144:107121. doi: 10.1016/j.bioorg.2024.107121. Epub 2024 Jan 14. Bioorg Chem. 2024. PMID: 38237392 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3 results

Search Page